BOCH
OMGA

Blue Owl Capital Holdings’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Blue Owl Capital Holdings’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,055,882
Closed -$787K – 82
2024
Q4 		$787K Hold
1,055,882
– – 0.18% 35
2024
Q3 		$1.29M Hold
1,055,882
– – 0.25% 41
2024
Q2 		$2.19M Hold
1,055,882
– – 0.61% 28
2024
Q1 		$3.85M Hold
1,055,882
– – 0.77% 24
2023
Q4 		$3.18M Buy
+1,055,882
New +$2.14M 0.76% 24

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Blue Owl Capital Holdings's OMGA Position: Q1 2025 in Review

Blue Owl Capital Holdings sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 1,055,882 shares — an estimated $787K sold.

Blue Owl Capital Holdings first reported a position in OMGA in Q4 2023 and held it in 5 quarters. The position peaked at $3.85M in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Blue Owl Capital Holdings reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 1,055,882 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $787K.
  • Blue Owl Capital Holdings first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
  • Blue Owl Capital Holdings's Omega Therapeutics, Inc. Common Stock position peaked at $3.85M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2025, filed 15 May 2025.